MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
MD Medical Group Investments Plc (MDMG)
MD Medical Group Investments Plc: MD Medical Group announces board of directors changes
09-March-2022 / 16:05 MSK
Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
MD MEDICAL GROUP ANNOUNCES BOARD OF DIRECTORS CHANGES
9 March 2022 - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE, MOEX: MDMG), a leading Russian private healthcare provider, today announces changes in its Board of Directors.
Simon Rowlands decided to step down as a member of the Company's Board of Directors. The changes came into effect on March 9, 2022.
Notes:
1. This announcement contains inside information.
***
For further information please contact:
Investors
Media
Renata Battalova
EM
Head of Investor Relations
Tom Blackwell: +7 919 102 90 64
Tel.: +7 917 294 28 82
Sergii Pershyn: + 1 929 855 81 88
r.battalova@mcclinics.ru
MDMG@em-comms.com
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 47 modern healthcare facilities, including 8 hospitals and 39 out-patient clinics in 25 of the Russian regions. In 2021, MDMG's revenue amounted to RUB 25.2 billion, up 32% y-o-y. The Company's GDRs are traded on London Stock Exchange (LSE: MDMG) and Moscow Exchange (MOEX: MDMG).
ISIN: US55279C2008 Category Code: BOA TIDM: MDMG LEI Code: 213800XKI6VHY4JBS612 Sequence No.: 148010 EQS News ID: 1298589
End of Announcement EQS News Service